Diligence memo · auto-generated · as of July 2, 2026
Nimble Rx, Inc.
Nimble Rx, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Nimble Rx, Inc. operates in Other, based in REDWOOD CITY.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Nimble Rx, Inc. has raised $15M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $15M on 2022-05-31.
Most recent recorded round closed around 2022-05-31.
Valuation (modeled)modeled
Provath models Nimble Rx, Inc. at approximately $126M (range $20M–$440M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 3.24× the median modeled value of Series A Other companies in 2022–2024 (1135 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.1 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 82% of Other peers (25015 compared).
Modeled value ranks above 85% of those peers.
Closest niche peers: Ness Well, Inc., Quantori, Inc., Qquv Investments 5, Llc, Applause Network TV, Inc., Trustworthy Co.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.